ArticleJournal of translational medicine2026
Low-dose MyoAAV 2A-mediated delivery of engineered micro-utrophin achieves pan- muscle tissue distribution with elevated muscle function in Duchenne muscular dystrophy.
Na Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.